Showing results (11-20 of 156) with videos related to

Sort By:
Pageof 16
Journal of Gastroenterology and Hepatology|February 20, 2014
Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver diseaseWah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva
Hepatology International|March 20, 2015
A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosisWah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva
Therapeutic Advances in Endocrinology and Metabolism|December 19, 2022
Non-invasive assessment of metabolic dysfunction-associated fatty liver diseaseC Vikneshwaran Chandra Kumar, Ruben Skantha, Wah-Kheong Chan
Helicobacter|September 8, 2011
Epidemiology of Helicobacter pylori infection and public health implicationsKhean-Lee Goh, Wah-Kheong Chan, Seiji Shiota, et al.
World Journal of Gastroenterology|October 24, 2014
Split-dose vs same-day reduced-volume polyethylene glycol electrolyte lavage solution for morning colonoscopyWah-Kheong Chan, Najib Azmi, Sanjiv Mahadeva, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|June 10, 2020
Epidemiological differences of common liver conditions between Asia and the WestThevaraajan Jayaraman, Yeong-Yeh Lee, Wah-Kheong Chan, et al.
Journal of Gastroenterology and Hepatology|August 16, 2024
Vitamin E improves serum markers and histology in adults with metabolic dysfunction-associated steatotic liver disease: Systematic review and meta-analysisNicholas Ming-Zher Chee, Ram Prasad Sinnanaidu, Wah-Kheong Chan
Plos One|September 4, 2014
Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis--a comparison with routine biochemical markersWah-Kheong Chan, Pavai Sthaneshwar, Nik Raihan Nik Mustapha, et al.
Clinical Nutrition ESPEN|September 22, 2023
A systematic review on factors associated with non-alcoholic fatty liver disease (NAFLD) among adolescentsVishnu Raj S, Maslinor Ismail, Wah-Kheong Chan, et al.
Nephrology (Carlton, Vic.)|June 3, 2023
Is metabolic-dysfunction-associated fatty liver disease or advanced liver fibrosis associated with erythropoietin stimulating agent hypo-responsiveness among patients with end-stage kidney disease on haemodialysis?Wei-Kei Wong, Wah-Kheong Chan, Shubash Ganapathy, et al.
Pageof 16